搜尋
Artelo Biosciences Inc
ARTL添加自選
0.766USD
+0.011+1.40%
收盤 07-31 16:00（美東）報價延遲15分鐘
515.39K總市值
虧損本益比TTM
關於 Artelo Biosciences Inc 公司
Artelo Biosciences, Inc. is a clinical-stage pharmaceutical company dedicated to the development and commercialization of therapeutics that modulate lipid-signaling pathways. The Company is advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, anxiety, dermatologic conditions, pain, and inflammation. Its pipeline products include ART26.12, ART27.13 and ART12.11. ART26.12, its Fatty Acid Binding Protein 5 (FABP5) inhibitor, is being developed as a novel, peripherally acting, non-opioid, non-steroidal analgesic. The Cancer Appetite Recovery Study (CAReS) is a Phase 1/2 randomized, placebo-controlled trial of its clinical program, ART27.13, in patients with cancer anorexia and weight loss. ART12.11, the Company's novel solid-state cannabidiol composition co-formed with tetramethylpyrazine, is targeted for development in anxiety disorders and rare/orphan diseases.
Artelo Biosciences Inc簡介
公司代碼ARTL
公司名稱Artelo Biosciences Inc
上市日期Oct 13, 2015
CEOGorgas (Gregory D)
員工數量6
證券類型Ordinary Share
年結日Oct 13
公司地址505 Lomas Santa Fe, Suite 160
城市SOLANA BEACH
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編92075
電話18589257049
網址https://artelobio.com/
公司代碼ARTL
上市日期Oct 13, 2015
CEOGorgas (Gregory D)
Artelo Biosciences Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Gregory D. (Greg) Gorgas
Mr. Gregory D. (Greg) Gorgas
President, Chief Executive Officer, Secretary, Director
President, Chief Executive Officer, Secretary, Director
1.14K
-253.79%
Ms. Connie L. Matsui
Ms. Connie L. Matsui
Independent Chairperson of the Board
Independent Chairperson of the Board
210.00
-5488.57%
Mr. Steven (Steve) Kelly
Mr. Steven (Steve) Kelly
Independent Director
Independent Director
47.00
--
Dr. Douglas Blayney, M.D.
Dr. Douglas Blayney, M.D.
Independent Director
Independent Director
--
--
Dr. R. Martin Emanuele, Ph.D.
Dr. R. Martin Emanuele, Ph.D.
Independent Director
Independent Director
--
--
Dr. Gregory R. Reyes, M.D., Ph.D.
Dr. Gregory R. Reyes, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Tamara A. (Seymour) Favorito, CPA
Ms. Tamara A. (Seymour) Favorito, CPA
Independent Director
Independent Director
--
--
Mr. Mark E. Spring, CPA
Mr. Mark E. Spring, CPA
Chief Financial Officer, Treasurer, Principal Financial Officer, Principal Accounting Officer
Chief Financial Officer, Treasurer, Principal Financial Officer, Principal Accounting Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Gregory D. (Greg) Gorgas
Mr. Gregory D. (Greg) Gorgas
President, Chief Executive Officer, Secretary, Director
President, Chief Executive Officer, Secretary, Director
1.14K
-253.79%
Ms. Connie L. Matsui
Ms. Connie L. Matsui
Independent Chairperson of the Board
Independent Chairperson of the Board
210.00
-5488.57%
Mr. Steven (Steve) Kelly
Mr. Steven (Steve) Kelly
Independent Director
Independent Director
47.00
--
Dr. Douglas Blayney, M.D.
Dr. Douglas Blayney, M.D.
Independent Director
Independent Director
--
--
Dr. R. Martin Emanuele, Ph.D.
Dr. R. Martin Emanuele, Ph.D.
Independent Director
Independent Director
--
--
Dr. Gregory R. Reyes, M.D., Ph.D.
Dr. Gregory R. Reyes, M.D., Ph.D.
Independent Director
Independent Director
--
--
常見問題
Artelo Biosciences Inc的前五大股東是誰？
Artelo Biosciences Inc的前五大股東如下：Mr. Gregory D. (Greg) Gorgas
有多少機構持有Artelo Biosciences Inc(ARTL)的股份？
截至2026Q1，共有21家機構持有Artelo Biosciences Inc的股份，合計持有的股份價值約為34.88K，占公司總股份的3.72% 。與2025Q4相比，機構持股有所增加，增幅為10331.00。